--- title: "IMMUNITRACK ApS – CVR 32347908, financials and ownership" description: "IMMUNITRACK ApS (CVR 32347908). Dissolved · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · København Ø. 16 employees (CVR) (Nov 2023). Gross profit 142M DKK (2024)." canonical_url: "https://datapublica.dk/en/companies/32347908-immunitrack-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # IMMUNITRACK ApS IMMUNITRACK ApS \(CVR 32347908\). Dissolved · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · København Ø. 16 employees \(CVR\) \(Nov 2023\). Gross profit 142M DKK \(2024\). CVR number: 32347908 ## Company details - **CVR number:** 32347908 - **Status:** Opløst - **Address:** Lersø Parkallé 42 4, 2100, København Ø - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Dec 20, 2013 - **Employees / FTEs:** 16 / 2 · Nov 2023 - **Production units:** 0 ## Description Description of key activities of the company Immunitrack is a commercially active biotech company covering three major business areas including \(i\) provision of research and development services to pharma and biotechnology companies as well as academic research groups interested in mapping epitopes from cancer, viruses and therapeutics that can elicit an adaptive immune response, \(ii\) advancement of novel TCR like antibodies \(TCRLA\) and \(iii\) development of a novel AI software platform for more accurate predictions of T-cell epitopes. Development in activities and financial matters During the financial year, the entity sold its intangible asstets to US parent company and gaind a profit of t.DKK 141.681. After the sales the entity activity consists of income from the operation of machinery and laboratory equipment and leaseshold. Income or loss from ordinary activities after tax totals t.DKK 110.009 against t.DKK 8.356 last year and the balancesheet at 31. of december 2024 shows an equity of t.DKK 21.212. Management considers the net profit for the year satisfactory. In 2025 the company is expected to merge with Eli Lilly Danmark A/S. ## Activities and industry - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Latest financial period - **Reporting period:** 2024 - **Currency:** DKK - **Gross profit:** 141,975,865 - **Operating profit:** 140,052,566 - **Profit after tax:** 110,009,470 - **Assets:** 24,768,522 - **Equity:** 21,211,816 ## Founders | Founder | Registered as founder | Current roles | Ownership | | --- | --- | --- | --- | | [Stephan Pascal Thorgrimsen](https://datapublica.dk/en/people/pid_entity_4004157145-stephan-pascal-thorgrimsen) | Dec 20, 2013 | — | — | ## People No current people or role data available ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | Grant Thornton, Godkendt Revisionspartnerselskab | Henrik Nordentoft Jensen | statsautoriseret revisor | Jun 30, 2025 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) Advertising protected Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/) Protected entities: Company | Contact | Phone | Email | | --- | --- | --- | | Company | 2868\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F32347908-immunitrack-aps) | st\*\*\*@immunitrack.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F32347908-immunitrack-aps) | Branches \(1\) IMMUNITRACK ApS · Lersø Parkallé 42 4 · P-1018996231 | Contact | Phone | Email | | --- | --- | --- | | Company | 2868\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F32347908-immunitrack-aps) | th\*\*\*\*\*@gmail.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F32347908-immunitrack-aps) | ## Legal owners ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerELI LILLY DANMARK A/S | Ownership100 % | Voting rights100 % | FromOct 2, 2023 | ToJan 1, 2026 | | OwnerTingle Creek Ltd. | Ownership15–19.99 % | Voting rights15 % | FromMar 1, 2023 | ToOct 2, 2023 | | OwnerJustesen Enterprises ApS | Ownership25–33.32 % | Voting rights25 % | FromSep 1, 2022 | ToOct 2, 2023 | | OwnerLicorne Enterprises ApS | Ownership25–33.32 % | Voting rights25 % | FromSep 1, 2022 | ToOct 2, 2023 | | OwnerHorseferry Trading Pte. Ltd. | Ownership15–19.99 % | Voting rights15 % | FromOct 20, 2020 | ToOct 2, 2023 | | OwnerTingle Creek Ltd. | Ownership10–14.99 % | Voting rights10 % | FromMar 29, 2021 | ToFeb 28, 2023 | | OwnerJustesen Enterprises ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromNov 1, 2020 | ToAug 31, 2022 | | OwnerLicorne Enterprises ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromNov 1, 2020 | ToAug 31, 2022 | | OwnerBitter Sweet $ Symphony Holding ApS | Ownership66.67–89.99 % | Voting rights66.67 % | FromAug 31, 2018 | ToOct 31, 2020 | | OwnerHorseferry Trading Pte. Ltd. | Ownership15–19.99 % | Voting rights20 % | FromOct 1, 2020 | ToOct 19, 2020 | | OwnerBlenheim Al Health Limited | Ownership15–19.99 % | Voting rights20 % | FromFeb 27, 2019 | ToOct 1, 2020 | | OwnerBlenheim Al Health Limited | Ownership5–9.99 % | Voting rights5 % | FromAug 31, 2018 | ToFeb 26, 2019 | | OwnerBitter Sweet $ Symphony Holding ApS | Ownership100 % | Voting rights100 % | FromDec 20, 2013 | ToAug 30, 2018 | ## Child companies ### Previous | Company | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | CompanyIASO ApS | Ownership100 % | Voting rights100 % | FromDec 31, 2022 | ToJan 1, 2026 | | CompanyIASO ApS | Ownership100 % | Voting rights100 % | FromDec 28, 2020 | ToJun 9, 2021 | ## Company pages - [Overview](https://datapublica.dk/en/companies/32347908-immunitrack-aps) - [Financial report](https://datapublica.dk/en/companies/32347908-immunitrack-aps/financials) - [Risk](https://datapublica.dk/en/companies/32347908-immunitrack-aps/risk) - [Timeline](https://datapublica.dk/en/companies/32347908-immunitrack-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/32347908-immunitrack-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/32347908-immunitrack-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/32347908-immunitrack-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/32347908-immunitrack-aps/investments) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/32347908)